These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10222700)

  • 21. Tick-borne encephalitis vaccines: past and present.
    Zent O; Bröker M
    Expert Rev Vaccines; 2005 Oct; 4(5):747-55. PubMed ID: 16221075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Problematic shortage of TBE vaccine. The vaccination interval might need adjustment].
    Lindquist L; Günther G
    Lakartidningen; 2008 Aug 27-Sep 2; 105(35):2322-3. PubMed ID: 18831437
    [No Abstract]   [Full Text] [Related]  

  • 23. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX; Holzmann H; Essl A; Kundi M
    Vaccine; 2007 Oct; 25(43):7559-67. PubMed ID: 17869389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe forms of tick-borne encephalitis in children.
    Cizman M; Rakar R; Zakotnik B; Pokorn M; Arnez M
    Wien Klin Wochenschr; 1999 Jun; 111(12):484-7. PubMed ID: 10420507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there a need for a travel vaccination against tick-borne encephalitis?
    Kunze U
    Travel Med Infect Dis; 2008 Nov; 6(6):380-3. PubMed ID: 18984485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
    Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
    Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Before the next ticks season: vaccinate children older than 7 years living in endemic regions against TBE but let the small children get away].
    Skogman BH; Nilsson L; Croner S; Forsberg P
    Lakartidningen; 2004 Oct; 101(43):3367; author reply 3367-8. PubMed ID: 15543961
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of serum levels of tick-borne encephalitis (TBE) virus antibodies after administration of FSME inject vaccine].
    Pancewicz SA; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2002; 56 Suppl 1():116-21. PubMed ID: 12194225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statement on tick-borne encephalitis. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine and Travel (CATMAT)
    Can Commun Dis Rep; 2006 Apr; 32(ACS-3):1-18. PubMed ID: 16710945
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology of TBE].
    Süss J; Klaus C
    MMW Fortschr Med; 2006 Jun; 148(22):35-9. PubMed ID: 16821579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update tick-borne encephalitis].
    Kaiser R
    MMW Fortschr Med; 2009 Mar; 151(11):38-9. PubMed ID: 19469203
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early-summer meningo-encephalitis (ESME) and ESME-vaccination: status 2000].
    Kunze U; Bernhard G; Böhm G; Groman E
    Wien Med Wochenschr; 2000; 150(5):103-8. PubMed ID: 10838715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunisation against tick-borne encephalitis by widely used vaccines: short-term history and current recommendations.
    Beran J
    Clin Microbiol Infect; 2005 May; 11(5):424-6. PubMed ID: 15819877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.